Zheng Ya, Liu Xun
Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing, China; Department of Psychology, Dalian Medical University, Dalian, China.
Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences, Beijing, China.
Neuropsychologia. 2015 May;71:173-80. doi: 10.1016/j.neuropsychologia.2015.04.002. Epub 2015 Apr 3.
The sensation-seeking trait is a valid predictor of various risk-taking behaviors. However, the neural underpinnings of risk processing in sensation seeking are yet unclear. The present event-related potential (ERP) study examined electrophysiological correlates associated with different stages of risky reward processing in sensation seeking. Twenty-one high sensation seekers (HSS) and 22 low sensation seekers (LSS) performed a simple two-choice gambling task. Behaviorally, whereas LSS exhibited a risk-averse pattern, HSS showed a risk-neutral pattern. During the anticipation stage, an increased stimulus-preceding negativity was elicited by high-risk compared to low-risk choices in LSS but not in HSS. During the outcome-appraisal stage, the feedback-related negativity, when calculated as the difference between losses and gains, was enhanced in response to the high-risk versus low-risk outcomes, which appeared for LSS but not for HSS. Further, HSS as compared to LSS exhibited a diminished P300 to both gains and losses. These findings suggest that risk-taking behavior in sensation seeking is expressed as blunted neural responses to risk in the anticipation stage and in the outcome-appraisal stage, which represents a candidate target for drug prevention.
寻求刺激特质是各种冒险行为的有效预测指标。然而,寻求刺激过程中风险处理的神经基础尚不清楚。本事件相关电位(ERP)研究考察了与寻求刺激中风险奖励处理不同阶段相关的电生理相关性。21名高寻求刺激者(HSS)和22名低寻求刺激者(LSS)进行了一项简单的二选一赌博任务。在行为上,LSS表现出风险厌恶模式,而HSS表现出风险中性模式。在预期阶段,与低风险选择相比,高风险选择在LSS中引发了刺激前负波增加,但在HSS中没有。在结果评估阶段,当以损失与收益之差计算时,反馈相关负波在LSS中对高风险与低风险结果的反应中增强,但在HSS中没有。此外,与LSS相比,HSS对收益和损失的P300均减弱。这些发现表明,寻求刺激中的冒险行为表现为在预期阶段和结果评估阶段对风险的神经反应减弱,这是药物预防的一个候选靶点。